SR

Shubham Rajesh Purushothaman

Active Director Director DIN 11246074
DIN 11246074 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubham Rajesh Purushothaman

Data last updated:

Shubham Rajesh Purushothaman is a Director at Neovira Therapeutics Private Limited (since 2025).

DIN 11246074
Primary Designation Director
First Appointment 18 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neovira Therapeutics Private Limited U72100KA2025PTC206700
Director18 Aug 20252025Active

Board colleagues of Shubham Rajesh Purushothaman

NameDINCompanyDesignation
Mehdi Totonchi11246075Neovira Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neovira Therapeutics Private Limited
Premium access

Shareholding and investment profile for Shubham Rajesh Purushothaman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Rajesh Purushothaman

Shubham Rajesh Purushothaman currently holds 1 directorship: Neovira Therapeutics Private Limited (Director, since 18 Aug 2025).

Shubham Rajesh Purushothaman was first appointed on 18 Aug 2025 as Director at Neovira Therapeutics Private Limited.

The current boards of Shubham Rajesh Purushothaman's companies include Mehdi Totonchi (Neovira Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available